Patients with sensitive skin require a personalized approach that takes into account the various possible biomedical, neural, and psychosocial factors that may be responsible.
Participation in 4 therapy seminars resulted in appreciable improvement in pruritus in patients with atopic dermatitis or psoriasis and may be an efficient supplementary method for managing chronic itch in these populations.
For patients undergoing hemodialysis who have moderate-to-severe pruritus, difelikefalin is associated with a significant reduction in itch intensity and improvement in itch-related quality of life.
Investigators evaluated the treatment of chronic pruritus with tofacitinib in patients with concomitant rheumatoid arthritis.
Data from this analysis indicate that dupilumab induces rapid improvements in AD that can be maintained long term in a significant percentage of Japanese adults with moderate to severe AD, with prolonged benefits in terms of both pruritus and QoL.
This phase 2 serlopitant study is the first randomized clinical trial for EB-related pruritus demonstrating safety and potential itch reduction.
A review of the unique transition-related medical and aesthetic dermatologic needs of patients undergoing transition.
It is crucial to identify effective strategies for improving the management and control of pruritus.
Itch is “learned” in the nervous system, said Dr Berger, with involvement by both central and peripheral neural processes.
Inflammatory pruritus may be more strongly associated with nociceptive symptoms than neuropathic pruritus.
